These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2301001)

  • 1. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients.
    Rabinowich H; Zeevi A; Paradis IL; Yousem SA; Dauber JH; Kormos R; Hardesty RL; Griffith BP; Duquesnoy RJ
    Transplantation; 1990 Jan; 49(1):115-21. PubMed ID: 2301001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients.
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz M
    Transplantation; 1992 Jan; 53(1):181-9. PubMed ID: 1310170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
    Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.
    Fung JJ; Zeevi A; Kaufman C; Paradis IL; Dauber JH; Hardesty RL; Griffith B; Duquesnoy RJ
    Hum Immunol; 1985 Nov; 14(3):287-94. PubMed ID: 3932269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients: can it be useful in monitoring rejection or infection?
    Shennib H; Lee AG; Serrick C; Giaid A
    Transplantation; 1996 Nov; 62(9):1262-7. PubMed ID: 8932269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific cytotoxic lymphocyte activity from bronchoalveolar lavage during acute canine lung allograft rejection.
    Sekine Y; Fujisawa T; Saitoh Y; Takeda T; Yoshida S; Urabe N; Baba M; Yamaguchi Y
    Eur J Cardiothorac Surg; 1997 May; 11(5):902-9. PubMed ID: 9196307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients.
    Zeevi A; Uknis ME; Spichty KJ; Tector M; Keenan RJ; Rinaldo C; Yousem S; Duncan S; Paradis I; Dauber J
    Transplantation; 1992 Oct; 54(4):635-9. PubMed ID: 1329281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
    Iacono A; Dauber J; Keenan R; Spichty K; Cai J; Grgurich W; Burckart G; Smaldone G; Pham S; Ohori NP; Yousem S; Williams P; Griffith B; Zeevi A
    Transplantation; 1997 Jul; 64(2):263-9. PubMed ID: 9256185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAL levels of interleukin-18 do not change before or during acute rejection in lungtransplant recipients.
    Ericson P; Lindén A; Riise GC
    Respir Med; 2004 Feb; 98(2):159-63. PubMed ID: 14971880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.
    Riise GC; Kjellström C; Ryd W; Scherstén H; Nilsson F; Mårtensson G; Andersson BA
    Eur Respir J; 1997 Aug; 10(8):1742-6. PubMed ID: 9272913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-dependent cell-mediated cytotoxicity and natural killer function in rejecting and infected lung allografts.
    Nguyen DM; Mulder DS; Shennib H
    Transplantation; 1993 Jun; 55(6):1250-6. PubMed ID: 8516810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoalveolar lavage fluid endotoxin elevation in human single lung transplant recipients during rejection.
    Lambert SB; Frazier-Jessen MR; VanStedum S; Hahn EL; Filkins JP; Garrity ER; Kovacs EJ
    Transpl Immunol; 1995 Mar; 3(1):81-5. PubMed ID: 7551984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bronchoalveolar lavage cells induce the histology of acute lung allograft rejection, and deposition of IgG2a in recipient murine lungs.
    Wilkes DS; Heidler KM; Bowen LK; Quinlan WM; Doyle NA; Cummings OW; Doerschuk CM
    J Immunol; 1995 Sep; 155(5):2775-83. PubMed ID: 7650403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients.
    Zeevi A; Fung JJ; Paradis IL; Dauber JH; Griffith BP; Hardesty RL; Duquesnoy RJ
    J Heart Transplant; 1985; 4(4):417-21. PubMed ID: 3939651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.
    Laan M; Lindén A; Riise GC
    Clin Exp Immunol; 2003 Aug; 133(2):290-6. PubMed ID: 12869037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted V beta usage by T cells infiltrating rejecting human lung allografts.
    DeBruyne LA; Lynch JP; Baker LA; Florn R; Deeb GM; Whyte RI; Bishop DK
    J Immunol; 1996 May; 156(9):3493-500. PubMed ID: 8617978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor.
    Clelland C; Higenbottam T; Stewart S; Otulana B; Wreghitt T; Gray J; Scott J; Wallwork J
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1386-92. PubMed ID: 8503549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics.
    Keenan RJ; Zeevi A; Iacono AT; Spichty KJ; Cai JZ; Yousem SA; Ohori NP; Paradis IL; Kawai A; Griffith BP
    Surgery; 1995 Aug; 118(2):385-91. PubMed ID: 7638755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bronchoalveolar IgG2/IgG1 ratio is a marker for human lung allograft rejection.
    Wilkes DS; Heidler KM; Niemeier M; Schwenk GR; Mathur PN; Breite WM; Cummings OW; Weissler JC
    J Investig Med; 1994 Dec; 42(4):652-9. PubMed ID: 8521028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.